Antitumor efficacy of CD137 ligation is maximized by the use of a CD137 single-chain Fv–expressing whole-cell tumor vaccine compared with CD137-specific monoclonal antibody infusion
Hongtao Zhang(Chinese Academy of Sciences), Ingegerd Hellström(Pacific Northwest Diabetes Research Institute), Keith L. Knutson(WinnMed), Mary L. Disis(University of Washington), Karl Erik Hellström(Bristol-Myers Squibb (Germany))
Cited by 15
Related Papers
National Survey of Drug-Resistant Tuberculosis in China
|New England Journal of Medicine|2012|649
ErbB receptors: from oncogenes to targeted cancer therapies
|Journal of Clinical Investigation|2007|578
Advances in clinical immunotherapy for gastric cancer
|Biochimica et Biophysica Acta (BBA) - Reviews on Cancer|2021|435
Current Landscape of Immunotherapy in Breast Cancer
|JAMA Oncology|2019|409